Ad is loading...
FNWFX
Price
$80.36
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
MDOBX
Price
$9.79
Change
-$0.07 (-0.71%)
Updated
Nov 15 closing price
Ad is loading...

FNWFX vs MDOBX

Header iconFNWFX vs MDOBX Comparison
Open Charts FNWFX vs MDOBXBanner chart's image
American Funds New World F3
Price$80.36
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
Morgan Stanley Developing Opportunity C
Price$9.79
Change-$0.07 (-0.71%)
VolumeN/A
CapitalizationN/A
FNWFX vs MDOBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. MDOBX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and MDOBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 60.9B vs. MDOBX (34M). FNWFX pays higher dividends than MDOBX: FNWFX (1.56) vs MDOBX (0.00). FNWFX was incepted earlier than MDOBX: FNWFX (8 years) vs MDOBX (5 years). FNWFX is a more actively managed with annual turnover of: 32.00 vs. MDOBX (15.00). MDOBX has a lower initial minimum investment than FNWFX: MDOBX (1000) vs FNWFX (1000000). MDOBX annual gain was more profitable for investors over the last year : 22.38 vs. FNWFX (11.59).
FNWFXMDOBXFNWFX / MDOBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years5 years-
Gain YTD7.14718.09439%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B34M179,118%
Annual Yield % from dividends1.560.00-
Returns for 1 year11.5922.3852%
Returns for 3 years-14.49-23.8761%
Returns for 5 years17.23N/A-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDU55.900.85
+1.54%
New Oriental Education and Technology Group
HTGC18.92-0.13
-0.68%
Hercules Capital
AZ6.49-0.11
-1.67%
A2Z Cust2Mate Solutions Corp
REPL10.80-0.60
-5.26%
Replimune Group
POAI0.69-0.05
-7.23%
Predictive Oncology